PROCEPT BioRobotics

Robotic Sales Representative - Japan

Japan

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Robotics & AutomationIndustries

Requirements

Candidates must possess a Bachelor’s degree in a relevant field, such as Business, Marketing, or Sales, and have a minimum of 5 years of experience in medical device sales, preferably in the robotics or surgical equipment industry. Demonstrated success in achieving and exceeding sales quotas is essential, along with strong knowledge of the Japanese healthcare market and its regulatory environment. Fluency in both English and Japanese is required, and the ability to build and manage relationships with key opinion leaders (KOLs) and hospital administrators is a significant advantage.

Responsibilities

The Robotic Sales Representative will be responsible for selling the Aquabeam Robotic System to hospitals in Japan, establishing Aquablation as the preferred treatment for BPH. This includes developing and executing sales plans, managing the complex sales process, building clinical and administrative support, identifying key institutions, generating market awareness, and driving sales within a defined territory. They will also manage the transition of initial sales to the Aquablation sales team, provide forecasts, communicate the value proposition of AquaBeam, and maintain relationships with customers and KOLs, collaborating with Sales Management and the Marketing team to prioritize customers and ensure customer satisfaction.

Skills

Sales
Robotic Systems
Relationship Building
Strategic Decision-Making
Technical Presentations
Market Awareness
Clinical Support
Administrative Support

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Key Metrics

Redwood City, CaliforniaHeadquarters
2009Year Founded
$319.1MTotal Funding
IPOCompany Stage
Robotics & Automation, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Parental Leave
Paid Holidays
Wellness Program
Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.
$175 million public stock offering could lead to shareholder dilution.
Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.
Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.
PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.
Global urology devices market projected to grow at 6.9% CAGR until 2030.
FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI